These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29644619)

  • 1. Early (≤ 30 Days), Late (31-360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
    Chen W; Wu Y; Hu Y
    Diabetes Ther; 2018 Jun; 9(3):1113-1124. PubMed ID: 29644619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.
    Li N; Yang YG; Chen MH
    BMC Cardiovasc Disord; 2016 Nov; 16(1):238. PubMed ID: 27887590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and Late Stent Thrombosis in Patients with Versus Without Diabetes Mellitus Following Percutaneous Coronary Intervention with Drug-Eluting Stents: A Systematic Review and Meta-Analysis.
    Yuan J; Xu GM
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):483-492. PubMed ID: 30132141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non-Insulin-Treated Diabetes Mellitus: Secondary Analysis of the TUXEDO Trial.
    Bangalore S; Bhagwat A; Pinto B; Goel PK; Jagtap P; Sathe S; Arambam P; Kaul U
    JAMA Cardiol; 2016 Jun; 1(3):266-73. PubMed ID: 27438104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials.
    Lin BY; Li P; Wu P; Jiang RN; Bundhun PK; Ahmed MA
    Adv Ther; 2019 Nov; 36(11):3166-3173. PubMed ID: 31535329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
    Wang Q; Liu H; Ding J
    Diabetes Ther; 2018 Jun; 9(3):1335-1345. PubMed ID: 29779197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis.
    Munnee K; Bundhun PK; Quan H; Tang Z
    Medicine (Baltimore); 2016 Mar; 95(10):e3006. PubMed ID: 26962814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.
    Lu H; Tang B; Zhou Y; Xu C; Bundhun PK; Tang Z; Bao H
    Diabetes Ther; 2019 Aug; 10(4):1487-1497. PubMed ID: 31256352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Yanamala CM; Huang WQ
    BMC Cardiovasc Disord; 2017 Mar; 17(1):84. PubMed ID: 28302055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
    Bundhun PK; Bhurtu A; Soogund MZ; Long MY
    PLoS One; 2016; 11(4):e0154064. PubMed ID: 27111304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
    Hillegass WB; Patel MR; Klein LW; Gurm HS; Brennan JM; Anstrom KJ; Dai D; Eisenstein EL; Peterson ED; Messenger JC; Douglas PS
    J Am Coll Cardiol; 2012 Dec; 60(22):2280-9. PubMed ID: 23194940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
    Seeger J; Wöhrle J; Scheller B; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger R; On Behalf Of The Basket-Small Investigators
    J Cardiovasc Dev Dis; 2023 Mar; 10(3):. PubMed ID: 36975883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era.
    Pi SH; Rhee TM; Lee JM; Hwang D; Park J; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Kim BJ; Kim BS; Gwon HC; Choi SH
    Am J Cardiol; 2018 Jun; 121(12):1505-1511. PubMed ID: 29751955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study.
    Simsek C; Räber L; Magro M; Boersma E; Onuma Y; Stefanini GG; Zanchin T; Kalesan B; Wenaweser P; Jüni P; van Geuns RJ; van Domburg RT; Windecker S; Serruys PW
    Int J Cardiol; 2013 Dec; 170(1):36-42. PubMed ID: 24196314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
    Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
    J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.
    Kalkman DN; Woudstra P; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    Int J Cardiol; 2017 Jan; 226():60-64. PubMed ID: 27788391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials.
    Bavishi C; Baber U; Panwar S; Pirrotta S; Dangas GD; Moreno P; Tamis-Holland J; Kini AS; Sharma SK
    Int J Cardiol; 2017 Mar; 230():310-318. PubMed ID: 28062139
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.